focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGulf Regulatory News (GIF)

Share Price Information for Gulf (GIF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.41
Bid: 2.38
Ask: 2.44
Change: 0.00 (0.00%)
Spread: 0.06 (2.521%)
Open: 2.41
High: 0.00
Low: 0.00
Prev. Close: 2.41
GIF Live PriceLast checked at -
Gulf Investment is an Investment Trust

To capture the opportunities for growth offered by the expanding GCC economies by investing in listed companies on one of the GCC exchanges or companies soon to be listed on one of the GCC exchanges.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Time-scheduled buy-back programme

22 Feb 2017 07:00

RNS Number : 4744X
Qatar Investment Fund PLC
22 February 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

22 February 2017

Qatar Investment Fund plc

("QIF" or the "Company")

Announcement of Time-Scheduled Buy-Back Programme

The Company today announces a time-scheduled buy-back programme in accordance with Commission Delegated Regulation (EU) 2016/1052 dated 8 March 2016 supplementing Regulation (EU) No 596/2014.

The ordinary share buy-back programme (the "Programme") has the sole purpose of reducing the issued ordinary share capital of the Company and as shares will not be acquired above the prevailing net asset value per share, it is also expected to enhance its Net Asset Value ("NAV") per share.

The Programme will commence with effect from today and will end, unless terminated earlier, on 17 November 2017. The Programme will be conducted in accordance with the authorisation granted to the Company by shareholders at the Annual General Meeting ("AGM") held on 18 November 2016 and the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014, to buy back up to 17,548,355 ordinary shares (being the equivalent of 14.99% of the Company's issued share capital at the date of the AGM notice). The maximum amount of money allocated to the Programme is $1,000,000.

Prior to the commencement of the Programme, the Company has effected share buy-backs under the authority granted by shareholders at the AGM on 18 November 2016 and has bought back a total of 234,832 ordinary shares.

Pursuant to, and during the term of, the Programme, the Company may purchase Ordinary Shares provided that:

1) the maximum price payable for an ordinary share on the Exchange is an amount equal to the higher of:

a. 105 per cent. of the average market value of the Company's Ordinary Shares as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which such share is contracted to be purchased; and

b. In order to benefit from the exemption laid down in Article 5(1) of Regulation (EU) No 596/2014, the Company will not purchase shares at a price higher than the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venue where the purchase is carried out, however the Company may exceed these levels in situations of low liquidity; and

2) the aggregate number of ordinary shares which may be acquired on behalf of the Company in connection with the Programme shall not exceed 17,313,523 ordinary shares.

Due to the limited liquidity in the ordinary shares, a buy-back of ordinary shares pursuant to the Programme on any trading day is likely to represent a significant proportion of the daily trading volume in the ordinary shares on the London Stock Exchange (and is likely to exceed the 25% limits of the average daily trading volume as laid down in Article 5(1) of Regulation (EU) No 596/2014 and as such the Company will not benefit from this exemption).

The average daily volume will be calculated based on the 20 trading days preceding the date of purchase required under Article 3(3) of the Commission Delegated Regulation (EU) 2016/1052 dated 8 March 2016.

The Company will announce any market repurchase of ordinary shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. To the extent permitted by law, ordinary shares bought back under the Programme will be held as treasury shares.

 

For further information, please contact:

 

Nicholas Wilson

+44 (0) 1624 622 851

Qatar Investment Fund plc

Ian Dungate/Suzanne Jones

+44 (0) 1624 692600

Galileo Fund Services Limited

Richard Gray/Andrew Potts

+44 (0) 20 7886 2500

Panmure Gordon

William Clutterbuck/Robbie Hynes

+44 (0) 20 7379 5151

Maitland

 

 

-ENDS-

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSEAKAFADFXEFF
Date   Source Headline
21st May 20244:30 pmRNSNotification of Major Holding in Company
17th May 20247:00 amRNSNet Asset Value(s)
15th May 20247:00 amRNSTender Offer
10th May 20247:00 amRNSNet Asset Value(s)
3rd May 20247:00 amRNSNet Asset Value(s)
29th Apr 202412:00 pmRNSTender Offer
26th Apr 20247:00 amRNSNet Asset Value(s)
19th Apr 20247:00 amRNSNet Asset Value(s)
12th Apr 20247:30 amRNSResult of Tender Offer
12th Apr 20247:00 amRNSNet Asset Value(s)
9th Apr 20247:00 amRNSQuarterly Report Q1 2024
5th Apr 20247:00 amRNSNet Asset Value(s)
2nd Apr 20247:00 amRNSNet Asset Value(s)
22nd Mar 20247:00 amRNSNet Asset Value(s)
21st Mar 20247:00 amRNSTender Offer
15th Mar 20247:00 amRNSNet Asset Value(s)
11th Mar 20244:30 pmRNSNotification of Major Holding
8th Mar 20247:00 amRNSNet Asset Value(s)
1st Mar 20247:00 amRNSNet Asset Value(s)
23rd Feb 20243:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20247:00 amRNSNet Asset Value(s)
22nd Feb 20247:00 amRNSHalf-year Report
16th Feb 20247:00 amRNSNet Asset Value(s)
9th Feb 20247:00 amRNSNet Asset Value(s)
8th Feb 20247:00 amRNSDividend Declaration
2nd Feb 20247:00 amRNSNet Asset Value(s)
26th Jan 20247:00 amRNSNet Asset Value(s)
24th Jan 20243:10 pmRNSAnnual Overview from QuotedData
19th Jan 20247:00 amRNSNet Asset Value(s)
12th Jan 20247:00 amRNSNet Asset Value(s)
11th Jan 20243:00 pmRNSQuarterly Report Q4 2023
5th Jan 20247:00 amRNSNet Asset Value(s)
29th Dec 20237:00 amRNSNet Asset Value(s)
27th Dec 20237:00 amRNSResult of AGM
22nd Dec 20237:00 amRNSNet Asset Value(s)
15th Dec 20237:00 amRNSNet Asset Value(s)
8th Dec 20237:00 amRNSNet Asset Value(s)
1st Dec 20237:00 amRNSNet Asset Value(s)
28th Nov 20237:00 amRNSPublication of circular, AGM and annual report
24th Nov 20237:00 amRNSNet Asset Value(s)
17th Nov 20237:00 amRNSNet Asset Value(s)
10th Nov 20237:00 amRNSNet Asset Value(s)
3rd Nov 20237:05 amRNSNet Asset Value(s)
31st Oct 20234:00 pmRNSNotification of Major Holdings
27th Oct 20239:00 amRNSCompletion of Tender Offer
27th Oct 20237:00 amRNSNet Asset Value(s)
20th Oct 202310:00 amRNSTender Offer
20th Oct 20237:00 amRNSNet Asset Value(s)
16th Oct 20233:00 pmRNSQuarterly Report 30 September 2023
13th Oct 20237:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.